Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01278719Unknown

The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study

Role: collaborator

NCT00327925Unknown

Blood Test for Ovarian Cancer Associated Antibodies (CAAb)

Role: lead

NCT00331942Unknown

Breast Cancer Associated Antibodies

Role: lead

All 3 trials loaded